Annals of Integrative Oncology

Annals of Integrative Oncology

Annals of Integrative Oncology

Annals of Integrative Oncology (ISSN: 2766-144X) is an open access, peer reviewed, International, multidisciplinary journal dedicated to promote research outcomes in cancer therapy.

Annals of Integrative Oncology

Annals of Integrative Oncology (ISSN: 2766-144X) is an open access, peer reviewed, International, multidisciplinary journal dedicated to promote research outcomes in cancer therapy.

Annals of Integrative Oncology (ISSN: 2766-144X) cover all the aspects which includes Healthcare Research, Leukemia, Immunology, medicine, genetics and other relevant topics associated within the scope of journal.

Editor & Editorial Board

Our esteemed Editorial panel

Anubha Bajaj

Anubha Bajaj

India

Adrián P. Huñis

Adrián P. Huñis

Argentina

Sorush Nik Namian

Sorush Nik Namian

United States

Zahaf Samir

Zahaf Samir

Algeria

Alain L. Fymat

Alain L. Fymat

United States

Freshteh Osmani

Freshteh Osmani

Iran (Islamic Republic of)

Meric Arda Esmekaya

Meric Arda Esmekaya

Turkey

Alireza Heidari

Alireza Heidari

United States

Recently Published Articles

Annals of Integrative Oncology aspires to publish journals that are exciting to read, educate, and keep the audience updated on cutting edge research in the fields of science, technology, medicine, surgery, oncology and oral health.

Ann Integrative Oncol | Volume 1, Issue 2 | 1009 | Open Access
Abstract | Fulltext PDF

Post-Progression Therapy after Chemoradiation and Consolidation Pembrolizumab: An Analysis from the Hoosier Cancer Research Network LUN 14-179 Phase 2 Clinical Trial

Meagan Miller, Nasser Hanna, Shadia Jalal, Salma K Jabbour, Robin Zon, Goetz Kloecker, Michael Williamson, Karen Reckamp, Ebenezer Kio, Robert Langdon, Bamidele Adesunloye, Ryan Gentzler, Wael Harb, Radhika Walling, Christina Yeon, Marianna Koczywas and Greg Durm

Share This Article:


Ann Integrative Oncol | Volume 1, Issue 2 | 1008 | Open Access
Abstract | Fulltext PDF

Evaluation of Serum Tumor Markers Variation, Following the Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer

Sorush Niknamian

Share This Article:


Ann Integrative Oncol | Volume 1, Issue 2 | 1006 | Open Access
Abstract | Fulltext PDF

Tumor Cell Identity as Projected by Immunotoxins within Heterogeneity and Hierarchical Systems of Progression

Agius LM

Share This Article:


Ann Integrative Oncol | Volume 1, Issue 1 | 1005 | Open Access
Abstract | Fulltext PDF

Effects of High Iodine Containing Low Osmolar Contrast Agent (Visipaque) on Thyroid Function Tests
 

Niknamian S

Share This Article:


Ann Integrative Oncol | Volume 1, Issue 1 | 1004 | Open Access
Abstract | Fulltext PDF

Complex Effectiveness of General Immunity in Modulating the Specific Immune Response in Gliomas

Lawrence M Agius

Share This Article:


Ann Integrative Oncol | Volume 1, Issue 1 | 1001 | Open Access
Abstract | Fulltext PDF

Neuroendocrine Carcinoma of the Breast: Epidemic, Clinicopathological Features and Treatment

Thi Hong Phan D, Anh Nguyen K. Duc Hong PT

Share This Article:


Subscribe to Our Newsletter